Re-treatment with ligelizumab is effective and generally well tolerated in patients with chronic spontaneous urticaria who ...

Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...

Patients with chronic spontaneous urticaria (CSU) often experience impaired QOL, especially when antihistamines, the standard ...

In this video, Jonathan A. Bernstein, MD, discusses an American College of Allergy, Asthma & Immunology Annual Scientific ...

In patients with chronic spontaneous urticaria, biomarkers such as a positive chronic urticaria index and low blood histamine ...

Diagnosed with severe CSU and angioedema in 2018, Jessica Tagg struggled for months with excruciating hives and painful ...

No advanced therapies approved to treat ColdU and SD—diseases of misery that dramatically impact all aspects of patient lifeBarzolvolimab is the ...

Doctors call it "urticaria," but everyone else calls it "hives." We're talking about the incredibly itchy, swollen rash that can suddenly show up on skin, without warning, only to disappear and show ...

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...

Celldex Therapeutics ($CLDX) announced an update on their ongoing clinical study. Celldex Therapeutics has completed a Phase 2 study titled A ...

Hines, a formerly registered Democrat who cried when Trump won in 2016, acknowledged the dramatic shift in her life.